{"title":"去极化剂和Na+通道抑制剂对大鼠大脑皮层毒蕈碱受体配体结合的影响。","authors":"B Hedlund","doi":"10.3891/acta.chem.scand.41b-0686","DOIUrl":null,"url":null,"abstract":"<p><p>In a vesicle preparation from rat cerebral cortex, carbachol recognizes a high-affinity and a low-affinity muscarinic agonist binding site. A number of agents, including veratridine (10 microM), gramicidin (10 microM) and valinomycin (10 microM), which depolarize the vesicles also appear to block the high-affinity muscarinic agonist binding site. Lowering [Na+] (from 137 to 80 mM) or raising [K+] (from 5 to 50 mM) produced effects similar to those of the depolarizing agents. Agents such as tetrodotoxin (1 microM), which block the Na+-channel, also appear to block the high-affinity agonist binding site or to convert it into a low-affinity agonist binding form.</p>","PeriodicalId":6886,"journal":{"name":"Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry","volume":"41 9","pages":"686-93"},"PeriodicalIF":0.0000,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Effects of depolarizing agents and Na+-channel inhibitors on ligand binding to muscarinic receptors from rat cerebral cortex.\",\"authors\":\"B Hedlund\",\"doi\":\"10.3891/acta.chem.scand.41b-0686\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In a vesicle preparation from rat cerebral cortex, carbachol recognizes a high-affinity and a low-affinity muscarinic agonist binding site. A number of agents, including veratridine (10 microM), gramicidin (10 microM) and valinomycin (10 microM), which depolarize the vesicles also appear to block the high-affinity muscarinic agonist binding site. Lowering [Na+] (from 137 to 80 mM) or raising [K+] (from 5 to 50 mM) produced effects similar to those of the depolarizing agents. Agents such as tetrodotoxin (1 microM), which block the Na+-channel, also appear to block the high-affinity agonist binding site or to convert it into a low-affinity agonist binding form.</p>\",\"PeriodicalId\":6886,\"journal\":{\"name\":\"Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry\",\"volume\":\"41 9\",\"pages\":\"686-93\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1987-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3891/acta.chem.scand.41b-0686\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3891/acta.chem.scand.41b-0686","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effects of depolarizing agents and Na+-channel inhibitors on ligand binding to muscarinic receptors from rat cerebral cortex.
In a vesicle preparation from rat cerebral cortex, carbachol recognizes a high-affinity and a low-affinity muscarinic agonist binding site. A number of agents, including veratridine (10 microM), gramicidin (10 microM) and valinomycin (10 microM), which depolarize the vesicles also appear to block the high-affinity muscarinic agonist binding site. Lowering [Na+] (from 137 to 80 mM) or raising [K+] (from 5 to 50 mM) produced effects similar to those of the depolarizing agents. Agents such as tetrodotoxin (1 microM), which block the Na+-channel, also appear to block the high-affinity agonist binding site or to convert it into a low-affinity agonist binding form.